ArticleClinical and experimental nephrology2011

Long-term complete response to very-low-dose interleukin-2 therapy in patients with metastatic renal cell carcinoma: report of two cases.

Ken-Ichi Harada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.